Patient Controlled Analgesia Pump Cues on Patient Satisfaction (PCA Cues)

August 11, 2021 updated by: Keri Hainsworth, Medical College of Wisconsin

The Effect of Patient Controlled Analgesia Pump Cues on Patient Satisfaction

To examine whether providing patients with a cue to the availability of pain medication affects patient satisfaction, patient anxiety, PCA efficacy, and safety.

Study Overview

Detailed Description

Post-operative pain is primarily managed via Patient-Controlled Analgesia (PCA). The newest PCA pumps can be programmed so that the button is backlit with a green light at the end of the lockout period, and the green light flashes when the medication is being dispensed. No studies have examined whether this type of visual cue would influence satisfaction or other patient outcomes (such as opioid consumption, PCA safety and patient anxiety) in children and adolescents, and no studies have examined whether pediatric patients' perspectives would be similar to those of adults.

Study Type

Interventional

Enrollment (Actual)

176

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53201
        • Children's Hospital of Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 7-18 years
  • Opioid naïve
  • Scheduled for a surgery for which a PCA is routinely used for post-operative pain management
  • At least 1 parent speaks English

Exclusion Criteria:

  • Prior experience with PCA
  • Cognitive delay precluding independent use of the PCA button
  • Current use of anxiolytics or antidepressants
  • Patients receiving epidural analgesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cues
The PCA pump will be programmed to provide a cue to the end of the lockout period.
The end of the lockout period will be cued via the PCA pump
Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups
Placebo Comparator: No Cues
The PCA pump will be programmed such that no cues will be provided to the end of the lockout period (current standard of care).
Morphine will be administered for post-operative pain in both the Cues and Non-Cues groups
The PCA pump will be programmed such that no cues will be provided to the end of the lockout period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Satisfaction Questionnaire
Time Frame: Up to 72 hours
Patient satisfaction with their PCA pump. Satisfaction was measured on a 0 to 10 scale, with higher numbers indicating greater satisfaction.
Up to 72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid Consumption (Total Amount of Opioid Consumed Post-operatively)
Time Frame: Post-op Days [POD] 0 - 2, up to 72 hours
Total amount of opioid consumed post-operatively in mg/kg/hour.
Post-op Days [POD] 0 - 2, up to 72 hours
Anxiety (State Anxiety on POD 1 and POD 2)
Time Frame: Up to 72 hours
State anxiety on POD 1 and POD 2. The total score is presented as a T-score, which ranges from 0 to 100, with higher scores indicating greater levels of state anxiety. With a T-score, the mean is always 50, and the standard deviation is always 10.
Up to 72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Keri R. Hainsworth, PhD, Medical College of Wisconsin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

October 3, 2019

Study Completion (Actual)

October 3, 2019

Study Registration Dates

First Submitted

April 27, 2015

First Submitted That Met QC Criteria

May 28, 2015

First Posted (Estimate)

May 29, 2015

Study Record Updates

Last Update Posted (Actual)

September 8, 2021

Last Update Submitted That Met QC Criteria

August 11, 2021

Last Verified

August 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Patient-Controlled Analgesia pump with Cues

Subscribe